Abstract |
Constitutive nuclear factor-kappaB ( NF-kappaB) activity plays a crucial role in the development and progression of lymphoma, leukemia, and some epithelial cancers. Given the contribution of NF-kappaB in carcinogenesis, a novel approach that interferes with its activity might have therapeutic potential against cancers that respond poorly to conventional treatments. Here, we have shown that a new IkappaB kinase beta inhibitor, IMD-0354, suppressed the growth of human breast cancer cells, MDA-MB-231, HMC1-8, and MCF-7, by arresting cell cycle and inducing apoptosis. In an electrophoretic mobility shift assay and a reporter assay, IMD-0354 abolished the NF-kappaB activity in MDA-MB-231 cells in a dose-dependent manner. In the cells incubated with IMD-0354, cell cycle arrested at the G0-G1 phase and apoptotic cells were increased. The expression of some cell cycle regulatory molecules and antiapoptotic molecules was suppressed in cells treated with IMD-0354. On the other hand, cyclin-dependent kinase suppressor p27Kip1 was up-regulated by the addition of IMD-0354. Daily administration of IMD-0354 inhibited tumor expansion in immunodeficient mice into which MDA-MB-231 cells were transplanted. These results indicate that NF-kappaB may contribute to cell proliferation through up-regulation of cell cycle progression; accordingly, inhibition of NF-kappaB activity might have a therapeutic ability in the treatment of human breast cancers.
|
Authors | Akane Tanaka, Susumu Muto, Masayo Konno, Akiko Itai, Hiroshi Matsuda |
Journal | Cancer research
(Cancer Res)
Vol. 66
Issue 1
Pg. 419-26
(Jan 01 2006)
ISSN: 0008-5472 [Print] United States |
PMID | 16397257
(Publication Type: Journal Article)
|
Chemical References |
- Benzamides
- NF-kappa B
- Protein Kinase Inhibitors
- RNA, Messenger
- Transforming Growth Factor beta
- N-(3,5-bis(trifluoromethyl)phenyl)-5-chloro-2-hydroxybenzamide
- I-kappa B Kinase
|
Topics |
- Animals
- Benzamides
(pharmacology)
- Breast Neoplasms
(drug therapy, enzymology, metabolism, pathology)
- Cell Cycle
(drug effects, physiology)
- Cell Line, Tumor
- Disease Progression
- Female
- Humans
- I-kappa B Kinase
(antagonists & inhibitors, metabolism)
- Mice
- Mice, Inbred BALB C
- Mice, Nude
- NF-kappa B
(antagonists & inhibitors, metabolism)
- Protein Kinase Inhibitors
(pharmacology)
- RNA, Messenger
(biosynthesis, genetics)
- Transforming Growth Factor beta
(biosynthesis, genetics)
- Xenograft Model Antitumor Assays
|